Financial Performance of Indian Pharmaceutical Companies: Analysis of Leverage and Cost of Capital

Main Article Content

Ahmed Mahdi Abdulkareem

Abstract

Purpose: The main aim of the study is to examine the performance of selected pharmaceutical companies in India based on the Degree Of Operating Leverage, Degree Of Financial Leverage, Degree Of Combined Leverage, and Cost Of Capital.


Approach/Methodology/Design: Five pharmaceutical companies were randomly selected, and the annual reports and financial statements of these companies were analyzed. The analysis methods involved Degree Of Operating Leverage, Degree Of Financial Leverage, Degree Of Combined Leverage, and Cost Of Capital. ANOVA test was also employed to test hypotheses. The study is made for five years from 2013-14 to 2017-18.


Findings: The results of the study reveal that there is a significant difference in the (means) variables in terms of leverage (operating, finance, and combined) and cost of capital. All leverages are different to each other and the cost of capital. The analysis reveals that Sun Pharma performed well during the study period, whereas Lupin underperformed in all aspects.


Practical Implications: The leverage and cost of capital are very important components for deciding whether to invest or not in pharmaceutical companies. The present study highlights the financial performances and growth of the selected pharmaceutical companies.


Originality/value: The results of the paper give certain indicators about the performance of the selected companies. These indicators can be used to inform an investment decision.

Article Details

How to Cite
Abdulkareem, A. M. (2020). Financial Performance of Indian Pharmaceutical Companies: Analysis of Leverage and Cost of Capital. Journal of Advanced Research in Economics and Administrative Sciences, 1(1), 13-22. https://doi.org/10.47631/jareas.v1i1.15
Section
Articles